drugset / Trial / NCT02785614

PK Study of Multi-dose Trazodone Hydrochloride Prolonged-released Tablets in Healthy Chinese

NCT02785614

Phase 1 Completed 12 enrolled Lee's Pharmaceutical Limited
RandomizedCrossoverOpen-labelTreatment

Summary

The main objective is to evaluate the pharmacokinetics comparative studies in a single dose, multiple dose

Timeline

Start
2017-05-01
Primary completion
2017-11-30
Completion
2018-01-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Trazodone Small molecule 50 mg Oral
Subject Trazodone Small molecule 150 mg Oral

Indications